HIGHLIGHTS
- who: Devin L. Wakefield from the TissueGnostics GmbH, Austria Yale University, United States have published the research: Using quantitative single molecule localization microscopy to optimize multivalent HER2-targeting ligands, in the Journal: (JOURNAL) of 17/04/2023
- what: Based on the analysis and lower frequencies of HER2 monomers were observed when TmemAb-AF647 was combined with multivalent meditopes. The authors show that mAb(s)/memAb-ligand treatments affect cell surface receptor clustering; the observed effects were dependent on ligand valency. The authors show that changes to HER2 organization at early time points are accompanied by . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.